Isolation and Treatment of Mouse CASMCs
Corresponding Organization : Virginia Commonwealth University
Variable analysis
- High phosphate (Pi) (3 mmol/L)
- TRMPL1 channel agonist, MLSA-1 (10 μM)
- TRMPL1 channel blocker, verapamil (10 μM)
- Not explicitly mentioned
- CASMCs cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin
- Cells incubated in humidified 100% air and 5% CO2 mixture at 37 °C
- Confluent cells (70%–80%) used for treatments
- Not explicitly mentioned
- Cells treated without high phosphate (Pi)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!